Synthesis and Biological Evaluation of Tricyclic Guanidine Analogues of Batzelladine K for Antimalarial, Antileishmanial, Antibacterial, Antifungal, and Anti‐HIV Activities. (28th March 2013)
- Record Type:
- Journal Article
- Title:
- Synthesis and Biological Evaluation of Tricyclic Guanidine Analogues of Batzelladine K for Antimalarial, Antileishmanial, Antibacterial, Antifungal, and Anti‐HIV Activities. (28th March 2013)
- Main Title:
- Synthesis and Biological Evaluation of Tricyclic Guanidine Analogues of Batzelladine K for Antimalarial, Antileishmanial, Antibacterial, Antifungal, and Anti‐HIV Activities
- Authors:
- Ahmed, Nafees
Brahmbhatt, Keyur G.
Khan, Shabana I.
Jacob, Melissa
Tekwani, Babu L.
Sabde, Sudeep
Mitra, Debashis
Singh, Inder P.
Khan, Ikhlas A.
Bhutani, Kamlesh K. - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Fifty analogues of batzelladine K were synthesized and evaluated for <italic>in vitro</italic> antimalarial (<italic>Plasmodium falciparum</italic>), antileishmanial (<italic>Leishmania donovani</italic>), antimicrobial (panel of bacteria and fungi), antiviral (HIV‐1) activities. Analogues <bold>14h</bold> and <bold>20l</bold> exhibited potential antimalarial activity against chloroquine‐sensitive D6 strain with IC<sub>50</sub> 1.25 and 0.88 μ<sc>m</sc> and chloroquine‐resistant W2 strain with IC<sub>50</sub> 1.64 and 1.07 μ<sc>m</sc>, respectively. Analogues <bold>12c</bold> and <bold>14c</bold> having nonyl substitution showed the most potent antileishmanial activity with IC<sub>50</sub> 2.39 and 2.78 μ<sc>m</sc> and IC<sub>90</sub> 11.27 and 12.76 μ<sc>m</sc>, respectively. Three analogues <bold>12c</bold>, <bold> 14c, </bold> and <bold>14i</bold> were the most active against various pathogenic bacteria and fungi with IC<sub>50</sub> < 3.02 μ<sc>m</sc> and MIC/MBC/MFC <6 μ<sc>m</sc>. Analogue <bold>20l</bold> having pentyl and methyl substituents on tricycle showed promising activities against all pathogens. However, none was found active against HIV‐1. Our study demonstrated that the tricyclic guanidine compounds provide new structural class for broad spectrum activity.</p> </abstract>
- Is Part Of:
- Chemical biology & drug design. Volume 81:Number 4(2013:Apr.)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 81:Number 4(2013:Apr.)
- Issue Display:
- Volume 81, Issue 4 (2013)
- Year:
- 2013
- Volume:
- 81
- Issue:
- 4
- Issue Sort Value:
- 2013-0081-0004-0000
- Page Start:
- 491
- Page End:
- 498
- Publication Date:
- 2013-03-28
- Subjects:
- Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.1427 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3525.xml